AstraZeneca Pharma India Limited Appeals Against Income Tax Order
Published On March 20, 2025
Overview of the Draft Order
AstraZeneca Pharma India Limited has recently received a draft order from the Income Tax Department’s assessment unit. Issued under Section 144C(1) in conjunction with Section 143(3) of the Income Tax Act, 1961, this order pertains to the assessment year 2022-23, dated March 19, 2025.
Company’s Response
In a regulatory filing, the company has confirmed its intention to file an appeal against the draft order. The official statement noted, “The matter will be challenged before the Dispute Resolution Panel by filing an appeal.”
Financial Implications
The draft order relates to a claim amounting to ₹ 11.96 crores, which excludes any interest and penalty for the stated assessment year. The company aims to resolve this issue through the appropriate legal channels.
